BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Down 93.3% in March

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 1,000 shares, a drop of 93.3% from the February 28th total of 15,000 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 16,000 shares, the days-to-cover ratio is presently 0.1 days.

BioNxt Solutions Trading Down 9.3 %

BNXTF traded down $0.04 on Wednesday, hitting $0.39. 200 shares of the company’s stock were exchanged, compared to its average volume of 10,215. The stock has a market cap of $44.50 million, a price-to-earnings ratio of -9.81 and a beta of 0.62. BioNxt Solutions has a fifty-two week low of $0.11 and a fifty-two week high of $0.43. The firm has a 50-day moving average price of $0.34 and a 200-day moving average price of $0.25.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.